Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
- Registration Number
- NCT02243813
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
Not provided
- Current or past history of meeting Diagnostic and Statistics Manual (DSM)-5 criteria for Schizophrenia, Psychotic Disorder (unless substance-induced or due to a medical condition), or Bipolar I or II Disorder
- Current or past history within the last 5 years of meeting DSM-5 criteria for alcohol or substance use disorder (excluding caffeine and nicotine) or severe major depression
- Have a first or second-degree relative with Schizophrenia, Psychotic Disorder (unless substance induced or due to a medical condition), or Bipolar I or II Disorder
- Has a psychiatric condition judged to be incompatible with establishment of rapport or safe exposure to psilocybin
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Immediate Participation Psilocybin Participants will begin psilocybin intervention immediately after study enrollment. Delayed Participation Psilocybin Participants will begin the psilocybin intervention 6 months after study enrollment.
- Primary Outcome Measures
Name Time Method Interim Questionnaire 6 months after enrollment This questionnaire asks about experiences and changes in attitudes, mood and behavior that occurred during the past 5 months. The questionnaire includes questions about salient spiritual experiences, changes in spiritual practices, changes in attitudes, moods, social interactions, and other behaviors related to participants' religious/spiritual vocation.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Behavioral Biology Research Center, Johns Hopkins Bayview
🇺🇸Baltimore, Maryland, United States